| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/16/2011 | US20110144018 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
| 06/16/2011 | US20110144017 Protein conjugates and methods for their preparation |
| 06/16/2011 | US20110144016 Methods and Compositions for Treating Cancer |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110144014 Cytokine receptor modulators and uses thereof |
| 06/16/2011 | US20110144013 VEGF-D Mutants and Their Use |
| 06/16/2011 | US20110144012 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
| 06/16/2011 | US20110144011 Cellular Activation Insulin Therapy |
| 06/16/2011 | US20110144010 Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier |
| 06/16/2011 | US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110144006 Protein composition |
| 06/16/2011 | US20110144005 Novel cyclic peptides |
| 06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 06/16/2011 | US20110144003 Maintenance therapy regime/regimen for the treatment of acne |
| 06/16/2011 | US20110144002 Use of AMPs for Treatment of UTI/Cystitis |
| 06/16/2011 | US20110144001 Highly bridged peptides from actinomadura namibiensis |
| 06/16/2011 | US20110144000 Antimicrobial polypeptide |
| 06/16/2011 | US20110143999 Fowlicidins and methods of its use |
| 06/16/2011 | US20110143998 Identification and use of peptide inhibitors of protein synthesis |
| 06/16/2011 | US20110143997 Phage receptor binding proteins for antibacterial therapy and other novel uses |
| 06/16/2011 | US20110143996 Antimicrobial kinocidin compositions and methods of use |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143994 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/16/2011 | US20110143993 Endothelial basement membrane targeting peptide ligands |
| 06/16/2011 | US20110143992 Methods and Compositions Related to GHS-R Antagonists |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142987 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 06/16/2011 | US20110142956 Use of a pde 5 inhibitor for treating and preventing hypopigmentary disorders |
| 06/16/2011 | US20110142953 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 06/16/2011 | US20110142949 Chondroitinase treatment method for demyelination-related conditions and diseases |
| 06/16/2011 | US20110142945 Hydrophobic Active Agent Compositions and Related Methods |
| 06/16/2011 | US20110142941 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof |
| 06/16/2011 | US20110142937 Methods and Compositions To Treat Hemorrhagic Conditions of The Brain |
| 06/16/2011 | US20110142927 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142923 Ophthalmic pharmaceutical compositions for the treatment of neoangiogenic pathologies of the eye |
| 06/16/2011 | US20110142919 Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142910 Clotting and Healing Compositions Containing Keratin Biomaterials |
| 06/16/2011 | US20110142908 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication |
| 06/16/2011 | US20110142907 Polymer for tissue bonding |
| 06/16/2011 | US20110142906 Implant Devices that Differ by Release Profile and Methods of Making and Using Same |
| 06/16/2011 | US20110142904 Methods for the In Situ Treatment of Bone Cancer |
| 06/16/2011 | US20110142901 Sustained release composition |
| 06/16/2011 | US20110142895 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/16/2011 | US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 06/16/2011 | US20110142889 Compositions and methods for oral drug delivery |
| 06/16/2011 | US20110142887 Methods and compositions for liquidation of tumors |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142881 Transcutaneous delivery of therapeutic agents |
| 06/16/2011 | US20110142876 Conjugated vi saccharides |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142868 Peptidylarginine Deiminase (PAD) Inhibitors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142854 Compositions and methods for inhibition of retroviruses |
| 06/16/2011 | US20110142850 Method of treating cd40-mediated diseases |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142839 Treatment of pulmonary edema |
| 06/16/2011 | US20110142837 Method Of Treating Acute Respiratory Distress Syndrome |
| 06/16/2011 | US20110142835 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
| 06/16/2011 | US20110142834 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 06/16/2011 | US20110142833 Methods for treating and preventing fibrosis |
| 06/16/2011 | US20110142832 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 06/16/2011 | US20110142820 Novel Targets for Regulation of Angiogenesis |
| 06/16/2011 | US20110142819 Method of improving would healing |
| 06/16/2011 | US20110142818 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 06/16/2011 | US20110142817 Means and method for treating and/or preventing necrotizing enterocolitis |
| 06/16/2011 | US20110142816 Thermostabilization of proteins |
| 06/16/2011 | US20110142815 Compounds, composition, methods, targets for cancer therapy |
| 06/16/2011 | US20110142812 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142800 Methods and compositions for oral administration of proteins |
| 06/16/2011 | US20110142799 Modulation of neurodegenerative disease by modulating xbp-1 activity |
| 06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
| 06/16/2011 | US20110142797 Method For Prophylaxis or Treatment of Feline Infectious Peritonitis |
| 06/16/2011 | US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors |
| 06/16/2011 | US20110142795 Methods of treating cognitive impairment |
| 06/16/2011 | US20110142794 Methods and Compositions to Determine the Chemosensitizing Dose of Suramin Used in Combination Therapy |
| 06/16/2011 | US20110142793 Composition for treating articular cartilage defect, and method of manufacture thereof |
| 06/16/2011 | US20110142792 Compositions for Increasing Polypeptide Stability and Activity, and Related Methods |
| 06/16/2011 | US20110142773 Composition and periodical delivery system for cellular rejuvenation |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | US20110142762 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110142756 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | DE102004037652B4 Verfahren zur Modulation der Genexpression durch Änderung des CpG Gehalts Process for the modulation of gene expression by changing the CpG content |
| 06/16/2011 | CA2820202A1 Method of reversing immune suppression of langerhans cells |
| 06/16/2011 | CA2785996A1 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | CA2784001A1 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783763A1 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | CA2783732A1 Pharmaceutical composition comprising oligopeptides |